Trial intelligence / Profile preview

Acupuncture with Adjuvant Chemotherapy for Gastric Cancer

NCT07098949Not yet recruiting

Sponsor
Guangzhou University of Chinese Medicine
Start
Aug 2025
Primary completion
Dec 2028
Countries
1
01

Overview

Randomised, single-blind trial (2 arms), sponsored by Guangzhou University of Chinese Medicine. Primary endpoint: Disease Free Survival at 5 years. Planned start Aug 2025; status: not yet recruiting.

Beyond the preview

Go deeper on NCT07098949.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07098949.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call